Cassava Sciences Inc (SAVA)
25.92
-0.29
(-1.11%)
USD |
NASDAQ |
Nov 04, 12:57
Cassava Sciences Total Liabilities (Quarterly): 54.59M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 54.59M |
| March 31, 2024 | 77.12M |
| December 31, 2023 | 14.20M |
| September 30, 2023 | 17.41M |
| June 30, 2023 | 17.90M |
| March 31, 2023 | 14.11M |
| December 31, 2022 | 7.295M |
| September 30, 2022 | 8.567M |
| June 30, 2022 | 9.011M |
| March 31, 2022 | 7.097M |
| December 31, 2021 | 12.87M |
| September 30, 2021 | 6.684M |
| June 30, 2021 | 4.825M |
| March 31, 2021 | 2.863M |
| December 31, 2020 | 2.10M |
| September 30, 2020 | 1.426M |
| June 30, 2020 | 1.314M |
| March 31, 2020 | 1.145M |
| December 31, 2019 | 1.387M |
| September 30, 2019 | 0.93M |
| June 30, 2019 | 0.982M |
| March 31, 2019 | 0.97M |
| December 31, 2018 | 0.511M |
| September 30, 2018 | 0.862M |
| June 30, 2018 | 1.287M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.758M |
| December 31, 2017 | 1.132M |
| September 30, 2017 | 1.01M |
| June 30, 2017 | 0.999M |
| March 31, 2017 | 0.883M |
| December 31, 2016 | 0.665M |
| September 30, 2016 | 2.167M |
| June 30, 2016 | 1.953M |
| March 31, 2016 | 3.344M |
| December 31, 2015 | 2.551M |
| September 30, 2015 | 2.586M |
| June 30, 2015 | 1.813M |
| March 31, 2015 | 1.20M |
| December 31, 2014 | 0.85M |
| September 30, 2014 | 2.383M |
| June 30, 2014 | 1.739M |
| March 31, 2014 | 1.618M |
| December 31, 2013 | 1.801M |
| September 30, 2013 | 37.50M |
| June 30, 2013 | 39.02M |
| March 31, 2013 | 41.46M |
| December 31, 2012 | 43.72M |
| September 30, 2012 | 46.93M |
| June 30, 2012 | 48.27M |
| March 31, 2012 | 51.51M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.145M
Minimum
Mar 2020
77.12M
Maximum
Mar 2024
13.78M
Average
7.295M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 76.47B |
| Eli Lilly and Co | 61.29B |
| Seelos Therapeutics Inc | 30.51M |
| Biomarin Pharmaceutical Inc | 1.438B |
| EyePoint Pharmaceuticals Inc | 95.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 243.57M |
| Shareholders Equity (Quarterly) | 188.97M |